article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio. The aim was to streamline workflows in healthcare facilities by reducing error-prone manual data entry for every customer.

Labelling 105
article thumbnail

Is a lack of real-time data holding trials back?

pharmaphorum

It’s 2020 and the digital revolution is well on its way. Yet, for clinical trials worldwide, real-time access to data is not the norm – and that lack can create a cascading set of issues affecting every aspect of a study. Critical decisions are too often being made in a digital data vacuum. Potentially catastrophic setbacks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Deviation investigation guidelines in the pharmaceutical industry

GMPSOP

In 2019 and 2020, warning letters were issued for “Adulterated Food and Supplements” at 36% and 33%, respectively. incorrect data entry). Failure to comply with regulations was the biggest (30%) reason for warning letters in 2021. It is likely to be caused by human error or another isolated event.

article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

The Biobank was launched in 2020, with an initial aim of enrolling at least 1,000 patients with locally advanced or metastatic solid tumours and haematologic malignancies undergoing standard of care therapy. Building a bank.